A detailed history of Aqr Capital Management LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Aqr Capital Management LLC holds 553,565 shares of JAZZ stock, worth $68.5 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
553,565
Previous 619,100 10.59%
Holding current value
$68.5 Million
Previous $66.1 Million 6.62%
% of portfolio
0.09%
Previous 0.1%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.57 - $116.37 $6.59 Million - $7.63 Million
-65,535 Reduced 10.59%
553,565 $61.7 Million
Q2 2024

Aug 14, 2024

SELL
$103.94 - $118.98 $13 Million - $14.9 Million
-125,546 Reduced 16.86%
619,100 $66.1 Million
Q1 2024

May 15, 2024

BUY
$115.19 - $132.77 $50.7 Million - $58.5 Million
440,363 Added 144.72%
744,646 $89.7 Million
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $14.3 Million - $17 Million
125,172 Added 69.89%
304,283 $37.4 Million
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $6.33 Million - $7.54 Million
51,871 Added 40.77%
179,111 $23.2 Million
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $3.09 Million - $3.71 Million
-25,218 Reduced 16.54%
127,240 $15.8 Million
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $5.53 Million - $6.62 Million
41,241 Added 37.08%
152,458 $22.3 Million
Q4 2022

Feb 14, 2023

BUY
$129.72 - $159.85 $10.2 Million - $12.6 Million
79,010 Added 245.32%
111,217 $17.7 Million
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $4.08 Million - $5.19 Million
32,207 New
32,207 $4.29 Million
Q1 2022

May 16, 2022

SELL
$129.64 - $160.7 $19.7 Million - $24.4 Million
-151,827 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$119.87 - $145.67 $39 Million - $47.4 Million
-325,496 Reduced 68.19%
151,827 $19.3 Million
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $61.9 Million - $88.9 Million
-481,068 Reduced 50.2%
477,323 $62.2 Million
Q2 2021

Aug 16, 2021

SELL
$160.2 - $186.42 $18.4 Million - $21.4 Million
-114,969 Reduced 10.71%
958,391 $169 Million
Q1 2021

May 17, 2021

BUY
$150.19 - $173.5 $9.02 Million - $10.4 Million
60,065 Added 5.93%
1,073,360 $176 Million
Q4 2020

Feb 16, 2021

SELL
$140.71 - $165.05 $40.9 Million - $48 Million
-290,936 Reduced 22.31%
1,013,295 $165 Million
Q3 2020

Nov 16, 2020

SELL
$105.46 - $144.13 $66.5 Million - $90.9 Million
-630,550 Reduced 32.59%
1,304,231 $184 Million
Q2 2020

Aug 17, 2020

SELL
$95.68 - $121.88 $40.1 Million - $51.1 Million
-419,046 Reduced 17.8%
1,934,781 $211 Million
Q1 2020

May 15, 2020

BUY
$87.74 - $152.74 $34 Million - $59.2 Million
387,575 Added 19.71%
2,353,827 $235 Million
Q4 2019

Feb 14, 2020

BUY
$117.65 - $153.73 $74.5 Million - $97.3 Million
633,022 Added 47.48%
1,966,252 $293 Million
Q3 2019

Nov 14, 2019

BUY
$125.18 - $143.24 $34.6 Million - $39.6 Million
276,211 Added 26.13%
1,333,230 $169 Million
Q2 2019

Aug 14, 2019

BUY
$125.55 - $144.48 $42.4 Million - $48.7 Million
337,396 Added 46.89%
1,057,019 $147 Million
Q1 2019

May 14, 2019

BUY
$121.81 - $142.95 $26.4 Million - $30.9 Million
216,323 Added 42.98%
719,623 $102 Million
Q4 2018

Feb 14, 2019

BUY
$115.94 - $166.74 $18.4 Million - $26.5 Million
158,987 Added 46.18%
503,300 $62.4 Million
Q3 2018

Nov 15, 2018

BUY
$161.01 - $180.57 $33.8 Million - $37.9 Million
210,156 Added 156.65%
344,313 $57.9 Million
Q2 2018

Aug 14, 2018

BUY
$146.33 - $183.18 $2.04 Million - $2.55 Million
13,948 Added 11.6%
134,157 $23.2 Million
Q1 2018

May 15, 2018

BUY
$135.59 - $157.16 $345,076 - $399,972
2,545 Added 2.16%
120,209 $18.2 Million
Q4 2017

Feb 14, 2018

BUY
$131.06 - $150.39 $11.7 Million - $13.5 Million
89,601 Added 319.29%
117,664 $15.8 Million
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $4 Million - $4.37 Million
28,063
28,063 $4.1 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.76B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.